Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide

Addington, 1998, Assessing depression in schizophrenia: the Calgary Depression Scale, Br. J. Psychiatry, 163, S39, 10.1192/S0007125000292581 Amador, 1993, Assessment of insight in psychosis, Am. J. Psychiatry, 150, 873, 10.1176/ajp.150.6.873 Amador, 1996, Suicidal behavior in schizophrenia and its relationship to awareness of illness, Am. J. Psychiatry, 153, 1185, 10.1176/ajp.153.9.1185 Arango, 1997, Postmortem findings in suicide victims. Implications for in vivo imaging studies, Ann. N. Y. Acad. Sci., 836, 269, 10.1111/j.1749-6632.1997.tb52365.x Beck, 1979, Assessment of suicidal intention: the scale for suicide ideation, J. Consult. Clin. Psychol., 2, 343, 10.1037/0022-006X.47.2.343 Bilder, 2000, Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates, Am. J. Psychiatry, 157, 549, 10.1176/appi.ajp.157.4.549 Black, 1992, Mortality in DSM-IIIR schizophrenia, Schizophr. Res., 7, 109, 10.1016/0920-9964(92)90040-C Bleuler, 1978 Breier, 1984, Characterization of schizophrenic patients who commit suicide, Am. J. Psychiatry, 141, 206, 10.1176/ajp.141.2.206 Buchanan, 1994, The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance, Biol. Psychiatry, 36, 717, 10.1016/0006-3223(94)90082-5 Caldwell, 1992, Schizophrenia: a high-risk factor for suicide: clues to risk reduction, Suicide Life-Threat. Behav., 22, 479, 10.1111/j.1943-278X.1992.tb01040.x 1989, 13 Cohen, 1964, Tranquilizers and suicide in schizophrenic patients, Arch. Gen. Psychiatry, 11, 312, 10.1001/archpsyc.1964.01720270084010 Cohen, 1994, Rates and correlates of suicide attempts in first-admission psychotic patients, Acta Psychiatr. Scand., 90, 167, 10.1111/j.1600-0447.1994.tb01573.x Collins, 1997, Insight, neurocognitive function and symptom clusters in chronic schizophrenia, Schizophr. Res., 27, 37, 10.1016/S0920-9964(97)00075-3 Fleming, 2001, The neurocognitive effects of Seroquel “quetiapine”: a preliminary study, J. Clin. Psychopharmacol., 21, 527, 10.1097/00004714-200110000-00011 Goldberg, 1993, The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia, Br. J. Psychiatry, 162, 43, 10.1192/bjp.162.1.43 Hagger, 1993, Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine, Biol. Psychiatry, 34, 702, 10.1016/0006-3223(93)90043-D Heila, 1997, Suicide in schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia, Am. J. Psychiatry, 154, 1235, 10.1176/ajp.154.9.1235 Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261 Kemp, 1996, Psychological predictors of insight and compliance in psychotic patients, Br. J. Psychiatry, 169, 444, 10.1192/bjp.169.4.444 Lindenmayer, 1994, A new five factor model of schizophrenia, Psychiatr. Q., 65, 299, 10.1007/BF02354306 Lindenmayer, 2001, The InterSePT Scale for Suicidal Thinking (ISST) reliability and validity, Schizophr. Res., 49, 5 Lipman, 1982, Differentiating anxiety and depression in anxiety disorders: use of rating scales, Psychopharmacol. Bull., 18, 69 Mann, 1999, Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior, Neuropsychopharmacology, 21, 99S, 10.1016/S0893-133X(99)00040-8 Meltzer, 1999, Suicide and schizophrenia: clozapine and the InterSePT study. International clozaril/leponex suicide prevention trial, J. Clin. Psychol., 60, 47 Meltzer, 1995, Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk–benefit assessment, Am. J. Psychiatry, 152, 183, 10.1176/ajp.152.2.183 Miles, 1977, Conditions predisposing to suicide: a review, J. Nerv. Ment. Dis., 164, 231, 10.1097/00005053-197704000-00002 Mortensen, 1993, Mortality and causes of death in first admitted schizophrenic patients, Br. J. Psychiatry, 163, 183, 10.1192/bjp.163.2.183 Newman, 1991, Mortality in a cohort of patients with schizophrenia: a record linkage study, Can. J. Psychiatry, 36, 239, 10.1177/070674379103600401 Potkin, 2001, Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics, J. Clin. Psychopharmacol., 21, 479, 10.1097/00004714-200110000-00004 Rennie, 1939, Follow-up study of five hundred patients with schizophrenia admitted to the hospital from 1913 to 1923, Arch. Neurol. Psychiatry, 32, 877, 10.1001/archneurpsyc.1939.02270230099008 Saykin, 1991, Neuropsychological function in schizophrenia: selective impairment in memory and learning, Arch. Gen. Psychiatry, 48, 618, 10.1001/archpsyc.1991.01810310036007 Walker, 1997, Mortality in current and former users of clozapine, Epidemiology, 6, 671, 10.1097/00001648-199710000-00010 Warnes, 1968, Suicide in schizophrenics, Dis. Nerv. Syst., 29, 35 Westermeyer, 1991, Risk for suicide in schizophrenia and other psychotic and nonpsychotic disorders, J. Nerv. Ment. Dis., 179, 259, 10.1097/00005053-199105000-00003